Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor: Complete Statistical AnalysisIndependent statistical analysis of Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04921800).
- Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI: Complete Statistical AnalysisIndependent statistical analysis of Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04097535).
- Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.: Complete Statistical AnalysisIndependent statistical analysis of Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output: Complete Statistical AnalysisIndependent statistical analysis of Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05070572).
- Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Meat Protein and Calcium: Do They Interact Synergistically or Antagonistically?: Complete Statistical AnalysisIndependent statistical analysis of Meat Protein and Calcium: Do They Interact Synergistically or Antagonistically?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00700804).
- Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias: Complete Statistical AnalysisIndependent statistical analysis of Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mechanisms of Antidepressant Non-Response in Late-Life Depression: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Antidepressant Non-Response in Late-Life Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01931202).
- Mechanisms of CBD for Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of CBD for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04044729).
- Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01671605).
- Mechanisms of Hypoglycemia Associated Autonomic Failure: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Hypoglycemia Associated Autonomic Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678145).
- Mechanisms of Lipodystrophy in HIV-Infected Pateints: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Lipodystrophy in HIV-Infected Pateints: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00457665).
- Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mechanisms of Refractory Hypertension (Reserpine): Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Refractory Hypertension (Reserpine): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03223272).
- Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MeCISIndependent statistical analysis of MethaCholine Bronchoprovocation Study (MeCIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00705341).
- MEDALISTIndependent statistical analysis of A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MEDEXIndependent statistical analysis of A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MEDEXIndependent statistical analysis of Mindfulness-Based Stress Reduction, Health Education and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02665481).
- MEDI8897 Ph2bComplete statistical analysis of the randomized phase 2 MEDI8897 Ph2b trial evaluating MEDI8897 for prevention of medically attended RSV lower respiratory tract infection in healthy preterm infants.
- Medication Treatment for Depression in Nursing Home Residents: Complete Statistical AnalysisIndependent statistical analysis of Medication Treatment for Depression in Nursing Home Residents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076622).
- Medications for Stopping Cocaine Dependence and Preventing Relapse: Complete Statistical AnalysisIndependent statistical analysis of Medications for Stopping Cocaine Dependence and Preventing Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00218023).
- MediGuide Registry: Complete Statistical AnalysisIndependent statistical analysis of MediGuide Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470312).
- MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: Complete Statistical AnalysisIndependent statistical analysis of MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MedOPTIndependent statistical analysis of Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MedstarBC2Independent statistical analysis of MedStar Diabetes Pathway Chart Reviews: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442595).
- Medtronic MiniMed Implantable Insulin Pump: Complete Statistical AnalysisIndependent statistical analysis of Medtronic MiniMed Implantable Insulin Pump: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298740).
- Medtronic Resolute Onyx 2.0 mm Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Medtronic Resolute Onyx 2.0 mm Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02412501).
- MEK InhibitorIndependent statistical analysis of MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096471).
- MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel47Independent statistical analysis of Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel55Independent statistical analysis of Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MelaOstrongIndependent statistical analysis of Melatonin and Osteogenic Loading on Osteopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04233112).
- Melatonin for Circadian Sleep Disorders in the Blind: Complete Statistical AnalysisIndependent statistical analysis of Melatonin for Circadian Sleep Disorders in the Blind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00911053).
- Melatonin in Smoke-induced Vascular Injury: Complete Statistical AnalysisIndependent statistical analysis of Melatonin in Smoke-induced Vascular Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02591238).
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Melatonin Postoperative Sleep Study in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Postoperative Sleep Study in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506064).
- Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02332928).
- Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MELTEMIIndependent statistical analysis of A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00305578).
- Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860597).
- MEMOIndependent statistical analysis of Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: Complete Statistical AnalysisIndependent statistical analysis of Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…
- Menopausal Sleep Fragmentation and Body Fat Gain: Complete Statistical AnalysisIndependent statistical analysis of Menopausal Sleep Fragmentation and Body Fat Gain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047330).
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805935).
- Mental Imagery Therapy for Autism (MITA) – an Early Intervention Computerized Language Training Program for Children With ASD: Complete Statistical AnalysisIndependent statistical analysis of Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD: primary endpoint results, effect estimate with confidence interval, sample-size planning…